Nuclear Medicine and Biology
Volume 33, Issue 2 , Pages 203-209 , February 2006

Characterization of a novel iodinated sigma-2 receptor ligand as a cell proliferation marker

  • Catherine Hou

      Affiliations

    • Department of Radiology, University of Pennsylvania, Philadelphia, PA 19104, USA
    • ,
  • Zhude Tu

      Affiliations

    • Department of Radiological Sciences, Washington University, St. Louis, MO, USA
    • ,
  • Robert Mach

      Affiliations

    • Department of Radiological Sciences, Washington University, St. Louis, MO, USA
    • ,
  • Hank F. Kung

      Affiliations

    • Department of Radiology, University of Pennsylvania, Philadelphia, PA 19104, USA
    • Department of Pharmacology, University of Pennsylvania, Philadelphia, PA 19104, USA
    • ,
  • Mei-Ping Kung

      Affiliations

    • Department of Radiology, University of Pennsylvania, Philadelphia, PA 19104, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 215 662 3989; fax: +1 215 349 5035.

Received 30 August 2005 ,Revised 3 October 2005 ,Accepted 4 October 2005.

References 

  1. Martin WRW, Boyes BE, Leenders KL, Patlak CS. A method for quantitative analysis of 6-fluorodopa uptake data from positron emission tomography. J Cereb Blood Flow Metab. 1985;5(Suppl 1):S593
  2. Su TP. Sigma receptors. Putative links between nervous, endocrine and immune systems. Eur J Biochem. 1991;200:633–642
  3. Quirion R, Bowen WD, Itzhak Y, Junien JL, Musacchio JM, Rothman RB, et al. A proposal for the classification of sigma binding sites. Trends Pharmacol Sci. 1992;13:85–86
  4. Bowen WD. Sigma receptors: recent advances and new clinical potentials. Pharm Acta Helv. 2000;74:211–218
  5. Hellewell SB, Bruce A, Feinstein G, Orringer J, Williams W, Bowen WD. Rat liver and kidney contain high densities of σ1 and σ2 receptors: characterization by ligand binding and photoaffinity labeling. Eur J Pharmacol. 1994;268:9–18
  6. Bowen WD, Bertha CM, Vilner BJ, Rice KC. CB-64D and CB-184: ligands with high σ2 receptor affinity and subtype selectivity. Eur J Pharmacol. 1995;278:257–260
  7. Bonhaus DW, Loury DN, Jakeman LB, To Z, DeSouza A, Eglen RM, et al. [3H]BIMU-1, a 5-hydroxy-tryptamine3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig brain hippocampus. J Pharmacol Exp Ther. 1993;267:961
  8. Vilner BJ, John CS, Bowen WD. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. Cancer Res. 1995;55:408–413
  9. John CS, Vilner BJ, Geyer BC, Moody T, Bowen WD. Targeting sigma receptor-binding benzamides as in vivo diagnostic and therapeutic agents for human prostate tumors. Cancer Res. 1999;59:4578–4583
  10. Waterhouse RN, Mardon K, Giles KM, Collier TL, O'Brien JC. Halogenated 4-(phenoxymethyl)piperidines as potential radiolabeled probes for sigma-1 receptors: in vivo evaluation of [123I]-1-(iodopropen-2-yl)-4-[(4-cyanophenoxy)methyl]piperidine. J Med Chem. 1997;40:1657–1667
  11. Shiue CY, Shiue GG, Zhang SX, Wilder S, Greenberg JH, Benard F, et al. N-(N-Benzylpiperidin-4-yl)-2-[18F]fluorobenzamide: a potential ligand for PET imaging of sigma receptors. Nucl Med Biol. 1997;24:671–676
  12. Dence CS, John CS, Bowen WD, Welch MJ. Synthesis and evaluation of [18F]labeled benzamides: high affinity sigma receptor ligands for PET imaging. Nucl Med Biol. 1997;24:333–340
  13. Mach RH, Smith CR, al-Nabulsi I, Whirrett BR, Childers SR, Wheeler KT. Sigma 2 receptors as potential biomarkers of proliferation in breast cancer. Cancer Res. 1997;57:156–161
  14. Wheeler KT, Wang LM, Wallen CA, Childers SR, Cline JM, Keng PC, et al. Sigma-2 receptors as a biomarker of proliferation in solid tumours. Br J Cancer. 2000;82:1223–1232
  15. Al-Nabulsi I, Mach RH, Wang LM, Wallen CA, Keng PC, Sten K, et al. Effect of ploidy, recruitment, environmental factors, and tamoxifen treatment on the expression of sigma-2 receptors in proliferating and quiescent tumour cells. Br J Cancer. 1999;81:925–933
  16. Walker JM, Bowen WD, Walker FO, Matsumoto RR, De Costa B, Rice KC. Sigma receptors: biology and function. Pharmacol Rev. 1990;42:355–402
  17. Garner SE, Kung M-P, Foulon C, Chumpradit S, Kung HF. [125I](S)-trans-7-OH-PIPAT: a potential SPECT imaging agent for sigma binding sites. Life Sci. 1994;54:593–603
  18. Choi SR, Yang B, Plössl K, Chumpradit S, Wey S-P, Acton PD, et al. Development of a Tc-99m labeled sigma-2 receptor-specific ligand as a potential breast tumor imaging agent. Nucl Med Biol. 2001;28:657–666
  19. Mach RH, Huang Y, Freeman RA, Wu L, Vangveravong S, Luedtkec RR. Conformationally-flexible benzamide analogues as dopamine D3 and σ2 receptor ligands. Bioorg Med Chem Lett. 2004;14:195–202
  20. Tu Z, Dence CS, Ponde DE, Jones L, Wheeler KT, Welch MJ, et al. Carbon-11 labeled σ2 receptor ligands for imaging breast cancer. Nucl Med Biol. 2005;32:423–430
  21. Mach RH, Kung MP, Tu Z, Vangveravong S, Wheeler KT, Kung HF, et al. Radioiodinated probes for imaging the s2 receptor status of breast tumors. In: 51st Annual meeting of Society of Nuclear Medicine, Philadelphia. 2004;[Abs. #485]
  22. Kung MP, Kung HF, Billings J, Yang Y, Murphy RA, Alavi A. The characterization of IBF as a new selective dopamine D-2 receptor imaging agent. J Nucl Med. 1990;31:648–654
  23. Scatchard G. Scatchard plot. Ann N Y Acad Sci. 1949;51:660–672
  24. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem. 1951;193:265–275
  25. Rockwell S. In vivo–in vitro tumor systems: new models for studying the response of tumors to therapy. Lab Anim Sci. 1977;27:831–851
  26. Choi N, Baumann M, Flentjie M, Kellokumpu-Lehtinen P, Senan S, Zamboglou N, et al. Predictive factors in radiotherapy for non-small cell lung cancer: present status. Lung Cancer. 2001;31:43–56
  27. Siggelkow W, Rath W, Buell U, Zimny M. FDG PET and tumour markers in the diagnosis of recurrent and metastatic breast cancer. Eur J Nucl Med Mol Imaging. 2004;31:S118–S124
  28. Acton PD, Choi SR, Plossl K, Kung HF. Quantification of dopamine transporters in the mouse brain using ultra-high resolution single-photon emission tomography. Eur J Nucl Med. 2002;29:691–698

PII: S0969-8051(05)00261-1

doi: 10.1016/j.nucmedbio.2005.10.001

Nuclear Medicine and Biology
Volume 33, Issue 2 , Pages 203-209 , February 2006

Article Tools

* Image Usage & Resolution